Frontiers in Genetics (Mar 2023)

Construction of copy number variation landscape and characterization of associated genes in a Bangladeshi cohort of neurodevelopmental disorders

  • Hosneara Akter,
  • Hosneara Akter,
  • Muhammad Mizanur Rahman,
  • Shaoli Sarker,
  • Shaoli Sarker,
  • Mohammed Basiruzzaman,
  • Mohammed Basiruzzaman,
  • Md. Mazharul Islam,
  • Md. Mazharul Islam,
  • Md. Atikur Rahaman,
  • Md. Ashiquir Rahaman,
  • Tamannyat Binte Eshaque,
  • Nushrat Jahan Dity,
  • Shouvik Sarker,
  • Md. Robed Amin,
  • Mohammad Monir Hossain,
  • Maksuda Lopa,
  • Nargis Jahan,
  • Shafaat Hossain,
  • Amirul Islam,
  • Amirul Islam,
  • Ashaduzzaman Mondol,
  • Md Omar Faruk,
  • Narayan Saha,
  • Gopen kumar Kundu,
  • Shayla Imam Kanta,
  • Rezaul Karim Kazal,
  • Kanij Fatema,
  • Md. Ashrafur Rahman,
  • Maruf Hasan,
  • Md. Abid Hossain Mollah,
  • Md. Ismail Hosen,
  • Noushad Karuvantevida,
  • Ghausia Begum,
  • Binte Zehra,
  • Nasna Nassir,
  • A. H. M. Nurun Nabi,
  • K. M. Furkan Uddin,
  • K. M. Furkan Uddin,
  • Mohammed Uddin,
  • Mohammed Uddin

DOI
https://doi.org/10.3389/fgene.2023.955631
Journal volume & issue
Vol. 14

Abstract

Read online

Introduction: Copy number variations (CNVs) play a critical role in the pathogenesis of neurodevelopmental disorders (NDD) among children. In this study, we aim to identify clinically relevant CNVs, genes and their phenotypic characteristics in an ethnically underrepresented homogenous population of Bangladesh.Methods: We have conducted chromosomal microarray analysis (CMA) for 212 NDD patients with male to female ratio of 2.2:1.0 to identify rare CNVs. To identify candidate genes within the rare CNVs, gene constraint metrics [i.e., “Critical-Exon Genes (CEGs)”] were applied to the population data. Autism Diagnostic Observation Schedule-Second Edition (ADOS-2) was followed in a subset of 95 NDD patients to assess the severity of autism and all statistical tests were performed using the R package.Results: Of all the samples assayed, 12.26% (26/212) and 57.08% (121/212) patients carried pathogenic and variant of uncertain significance (VOUS) CNVs, respectively. While 2.83% (6/212) patients’ pathogenic CNVs were found to be located in the subtelomeric regions. Further burden test identified females are significant carriers of pathogenic CNVs compared to males (OR = 4.2; p = 0.0007). We have observed an increased number of Loss of heterozygosity (LOH) within cases with 23.85% (26/109) consanguineous parents. Our analyses on imprinting genes show, 36 LOH variants disrupting 69 unique imprinted genes and classified these variants as VOUS. ADOS-2 subset shows severe social communication deficit (p = 0.014) and overall ASD symptoms severity (p = 0.026) among the patients carrying duplication CNV compared to the CNV negative group. Candidate gene analysis identified 153 unique CEGs in pathogenic CNVs and 31 in VOUS. Of the unique genes, 18 genes were found to be in smaller (<1 MB) focal CNVs in our NDD cohort and we identified PSMC3 gene as a strong candidate gene for Autism Spectrum Disorder (ASD). Moreover, we hypothesized that KMT2B gene duplication might be associated with intellectual disability.Conclusion: Our results show the utility of CMA for precise genetic diagnosis and its integration into the diagnosis, therapy and management of NDD patients.

Keywords